NEWS
Ericsson announces US $ 1 billion sale of iconectiv
The Transaction is subject to customary closing conditions , including regulatory approvals , with completion targeted during the first half of calendar 2025 .
iconectiv is consolidated by Ericsson and reported within Segment Enterprise . iconectiv ’ s contribution to Ericsson 2023 net income was approximately US $ 0.1 billion .
iconectiv is a US subsidiary of Ericsson acquired in 2012 as part of the Telcordia acquisition .
Ericsson has entered into a binding agreement with Koch
Equity Development LLC in relation to the sale of its US subsidiary iconectiv .
Ericsson ’ s cash benefit from the Transaction , after the settlement of anticipated taxes , transaction expenses and other liabilities , is expected to be approximately US $ 1 billion .
Ericsson expects to record a one-off EBIT benefit of approximately US $ 0.8 billion on closing of the Transaction .
Since 2017 , iconectiv has been co-owned with private equity firm Francisco Partners .
iconectiv serves over 5,000 customers across various sectors as a leading provider in number portability solutions and a provider of core network and operations management , numbering and data exchange services as its main segments and with limited strategic synergies with the rest of Ericsson ’ s portfolio .
The divestment will allow iconectiv to continue its growth trajectory under the new ownership of Koch Equity Development LLC .
Sapio Sciences and CREO announce strategic partnership
Lab informatics platform Sapio Sciences has entered a new strategic partnership with health consultancy CREO to deliver comprehensive , end-to-end laboratory information management solutions .
“ Seamless scientific workflow is at the heart of accelerating today ’ s medical breakthroughs ,” said Connie Pearcy , CREO ’ s Senior Managing Director of Digital Transformation .
This collaboration combines CREO ’ s digital transformation , validation and operational management expertise with Sapio Sciences ’ configurable lab informatics platform , LIMS , Electronic Lab Notebook , and Scientific Data Solutions .
By streamlining operations and increasing team collaboration and productivity , Sapio and CREO aim to accelerate science in research , clinical and molecular diagnostics and manufacturing environments .
This close collaboration will allow life sciences laboratories to navigate complex digital transformation journeys , from initial strategy to day-to-day management and continuous improvement .
“ When life sciences laboratories adopt integrated , data-driven solutions deeply aligned to their unique productivity and compliance requirements , they grow more effectively . By leveraging CREO ’ s strategic advisory and IT operational capabilities alongside Sapio ’ s innovative informatics platform , organizations can unlock new forms of operational excellence that empower their scientists to spend more time delivering world-class science .”
Andrew Wyatt , Chief Growth Officer , Sapio Sciences , said : “ CREO and Sapio have a shared vision of making life easier for scientists and better for everyone . This partnership will transform research and accelerate drug discovery by giving scientists access to best practice consulting from CREO and the most advanced lab informatics technology from Sapio .”
www . intelligentcio . com INTELLIGENTCIO NORTH AMERICA 11